HealthEquity EVP has shares withheld for taxes

HealthEquity, Inc. executive Michael Henry Fiore, EVP and Chief Commercial Officer, recorded a tax-withholding disposition of company stock.

Rhea-AI Filing Summary

HealthEquity, Inc. executive Michael Henry Fiore, EVP and Chief Commercial Officer, recorded a tax-withholding disposition of company stock. On April 6, 2026, 3,378 shares of common stock were withheld at $83.8363 per share to cover tax obligations, leaving him with 62,255 shares held directly. This was not an open-market purchase or sale but a share withholding to satisfy tax liability associated with equity compensation.

Insights

Equity compensation analyst

Routine tax withholding on equity, not an open-market trade.

The filing shows HealthEquity EVP Michael Henry Fiore had 3,378 shares of common stock withheld at $83.8363 per share to cover tax obligations tied to equity compensation. This is coded as a tax-withholding disposition, not a market transaction.

After this event, he directly holds 62,255 shares, indicating he retains a sizable equity stake. Because the transaction is mechanistic and not an open-market buy or sell, it carries limited informational value about his view of the stock and is best viewed as routine.

Insider Trade Summary

Exercise Price or Tax Liability: 3,378 shares

Exercise Price or Tax Liability 1 txn

Insider Fiore Michael Henry

Role EVP, CHIEF COMMERCIAL OFFICER

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	3,378	$83.8363	$283K

Holdings After Transaction: Common Stock — 62,255 shares (Direct)

Key Figures

Shares withheld for taxes: 3,378 shares Withholding price per share: $83.8363 per share Shares held after transaction: 62,255 shares

3 metrics

Shares withheld for taxes 3,378 shares Tax-withholding disposition on April 6, 2026

Withholding price per share $83.8363 per share Value used for tax-withholding disposition

Shares held after transaction 62,255 shares Direct ownership following tax withholding

Key Terms

tax-withholding disposition, Form 4, Common Stock, EVP, CHIEF COMMERCIAL OFFICER

4 terms

tax-withholding disposition financial

"transaction_action: "tax-withholding disposition""

A tax-withholding disposition is an event or transaction—such as selling or transferring securities, exercising options, or receiving compensation—that triggers a requirement to hold back part of the payment and remit it to tax authorities. It matters to investors because it reduces the cash they receive immediately and can change the timing and amount of taxable income, like a cashier taking a portion of your sale proceeds to pay taxes before you get the rest.

Form 4 regulatory

"INSIDER FILING DATA (Form 4)"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Common Stock financial

"security_title: "Common Stock""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

EVP, CHIEF COMMERCIAL OFFICER financial

"officer_title: "EVP, CHIEF COMMERCIAL OFFICER""

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did HealthEquity (HQY) report for Michael Henry Fiore?

HealthEquity reported that EVP and Chief Commercial Officer Michael Henry Fiore had 3,378 shares of common stock withheld for taxes. The shares were valued at $83.8363 each, reflecting a routine tax-withholding disposition linked to his equity compensation rather than an open-market trade.

Was the HealthEquity (HQY) Form 4 transaction an open-market sale or purchase?

The Form 4 transaction was not an open-market sale or purchase. It was a tax-withholding disposition, where 3,378 shares of common stock were delivered at $83.8363 per share to satisfy tax liabilities associated with Fiore’s equity compensation, a common administrative event.

How many HealthEquity (HQY) shares does Michael Henry Fiore hold after this filing?

Following the reported tax-withholding disposition, Michael Henry Fiore directly holds 62,255 shares of HealthEquity common stock. This post-transaction balance reflects his remaining ownership after 3,378 shares were used to cover tax obligations related to his stock-based compensation.

What does transaction code F mean in the HealthEquity (HQY) Form 4?

Transaction code F on the Form 4 indicates payment of an exercise price or tax liability by delivering securities. In this case, 3,378 shares of HealthEquity common stock were withheld at $83.8363 per share to cover Fiore’s tax obligations tied to his equity compensation award.

Does the HealthEquity (HQY) insider transaction suggest a change in insider sentiment?

The transaction mainly reflects tax withholding rather than a discretionary trade, so it offers limited insight into sentiment. Fiore’s 3,378 shares were withheld to cover tax liabilities, while he continues to hold 62,255 shares, indicating the event is primarily administrative in nature.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/08/2026 - 05:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Fiore Michael Henry

(Last) (First) (Middle)

C/O HEALTHEQUITY, INC.

15 W. SCENIC POINTE DR., STE. 100

(Street)

DRAPER UTAH 84020

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
HEALTHEQUITY, INC. [ HQY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, CHIEF COMMERCIAL OFFICER

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/06/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/06/2026		F		3,378	D	$83.8363	62,255	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Michael Fiore	04/08/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)